Item Type | Name |
Academic Article
|
Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation.
|
Academic Article
|
Heme-a, the heme prosthetic group of cytochrome c oxidase, is increased in Alzheimer's disease.
|
Academic Article
|
Reexamining Alzheimer's disease: evidence for a protective role for amyloid-beta protein precursor and amyloid-beta.
|
Academic Article
|
Mitochondria: a therapeutic target in neurodegeneration.
|
Academic Article
|
Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells.
|
Academic Article
|
Amyloid-beta-derived diffusible ligands cause impaired axonal transport of mitochondria in neurons.
|
Academic Article
|
NMR studies of zinc, copper, and iron binding to histidine, the principal metal ion complexing site of amyloid-beta peptide.
|
Academic Article
|
Novel therapeutics for Alzheimer's disease: an update.
|
Academic Article
|
Mitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies.
|
Academic Article
|
Mitochondria: the missing link between preconditioning and neuroprotection.
|
Academic Article
|
Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein.
|
Academic Article
|
Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease.
|
Academic Article
|
DLP1-dependent mitochondrial fragmentation mediates 1-methyl-4-phenylpyridinium toxicity in neurons: implications for Parkinson's disease.
|
Academic Article
|
The cell cycle regulator phosphorylated retinoblastoma protein is associated with tau pathology in several tauopathies.
|
Academic Article
|
The mitochondrial dynamics of Alzheimer's disease and Parkinson's disease offer important opportunities for therapeutic intervention.
|
Academic Article
|
Signaling effect of amyloid-beta(42) on the processing of AbetaPP.
|
Academic Article
|
Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease.
|
Academic Article
|
Cholesterol homeostasis markers are localized to mouse hippocampal pyramidal and granule layers.
|
Academic Article
|
Divalent metal transporter, iron, and Parkinson's disease: a pathological relationship.
|
Academic Article
|
Widespread distribution of reticulon-3 in various neurodegenerative diseases.
|
Academic Article
|
Biomarkers in Alzheimer's disease: past, present and future.
|
Academic Article
|
Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis.
|
Academic Article
|
AGEs/RAGE complex upregulates BACE1 via NF-?B pathway activation.
|
Academic Article
|
Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease.
|
Academic Article
|
Cellular prion protein is essential for oligomeric amyloid-?-induced neuronal cell death.
|
Academic Article
|
Amyloid-? peptide structure in aqueous solution varies with fragment size.
|
Academic Article
|
Hydroxynonenal-generated crosslinking fluorophore accumulation in Alzheimer disease reveals a dichotomy of protein turnover.
|
Academic Article
|
Isotyping the human TOMM40 variable-length polymorphism by gene amplification and restriction digest.
|
Academic Article
|
The structures of the E22? mutant-type amyloid-? alloforms and the impact of E22? mutation on the structures of the wild-type amyloid-? alloforms.
|
Academic Article
|
A novel origin for granulovacuolar degeneration in aging and Alzheimer's disease: parallels to stress granules.
|
Academic Article
|
LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1.
|
Academic Article
|
Amyloid Beta and tau proteins as therapeutic targets for Alzheimer's disease treatment: rethinking the current strategy.
|
Academic Article
|
Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.
|
Academic Article
|
Pathogenesis and disease-modifying therapy in Alzheimer's disease: the flat line of progress.
|
Academic Article
|
Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance.
|
Academic Article
|
Phosphorylation of tau protein as the link between oxidative stress, mitochondrial dysfunction, and connectivity failure: implications for Alzheimer's disease.
|
Academic Article
|
Proteolytic cleavage of polymeric tau protein by caspase-3: implications for Alzheimer disease.
|
Academic Article
|
Islet amyloid polypeptide (IAPP): a second amyloid in Alzheimer's disease.
|
Academic Article
|
Curcumin/melatonin hybrid 5-(4-hydroxy-phenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide ameliorates AD-like pathology in the APP/PS1 mouse model.
|
Academic Article
|
A novel SP1/SP3 dependent intronic enhancer governing transcription of the UCP3 gene in brown adipocytes.
|
Academic Article
|
Chronic effects of mild neurotrauma: putting the cart before the horse?
|
Academic Article
|
Tau, Amyloid Beta and Deep Brain Stimulation: Aiming to Restore Cognitive Deficit in Alzheimer's Disease.
|
Academic Article
|
Selenoprotein S Reduces Endoplasmic Reticulum Stress-Induced Phosphorylation of Tau: Potential Role in Selenate Mitigation of Tau Pathology.
|
Academic Article
|
Modulation of Parkinson's Disease Associated Protein Rescues Alzheimer's Disease Degeneration.
|
Academic Article
|
Identification of Inhibitors of CD36-Amyloid Beta Binding as Potential Agents for Alzheimer's Disease.
|
Academic Article
|
Elongation affinity, activation barrier, and stability of A?42 oligomers/fibrils in physiological saline.
|
Academic Article
|
1,3-propanediol binds deep inside the channel to inhibit water permeation through aquaporins.
|
Academic Article
|
Estrogen receptor-a is localized to neurofibrillary tangles in Alzheimer's disease.
|
Academic Article
|
Fibrillar Amyloid-? Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3?Tg-AD Transgenic Mouse.
|
Academic Article
|
Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein.
|
Academic Article
|
Rosmarinic acid prevents fibrillization and diminishes vibrational modes associated to ? sheet in tau protein linked to Alzheimer's disease.
|
Academic Article
|
Inhibition of mitochondrial fragmentation protects against Alzheimer's disease in rodent model.
|
Academic Article
|
Affinity and path of binding xylopyranose unto E.?coli xylose permease.
|
Academic Article
|
Markers of oxidative damage to lipids, nucleic acids and proteins and antioxidant enzymes activities in Alzheimer's disease brain: A meta-analysis in human pathological specimens.
|
Academic Article
|
Precision pharmacology for Alzheimer's disease.
|
Academic Article
|
Diminished O-GlcNAcylation in Alzheimer's disease is strongly correlated with mitochondrial anomalies.
|
Academic Article
|
Analysis of post-translational modifications in Alzheimer's disease by mass spectrometry.
|
Academic Article
|
The sterol regulatory element-binding protein 2 is dysregulated by tau alterations in Alzheimer disease.
|
Academic Article
|
Tau Biology, Tauopathy, Traumatic Brain Injury, and Diagnostic Challenges.
|
Academic Article
|
TMEM230 Accumulation in Granulovacuolar Degeneration Bodies and Dystrophic Neurites of Alzheimer's Disease.
|
Academic Article
|
Consequences of RNA oxidation on protein synthesis rate and fidelity: implications for the pathophysiology of neuropsychiatric disorders.
|
Academic Article
|
Incubation with Cu(II) and Zn(II) salts enhances MALDI-TOF mass spectra of amyloid-beta and a-synuclein toward in vivo analysis.
|
Academic Article
|
Characterization of Proteins Present in Isolated Senile Plaques from Alzheimer's Diseased Brains by MALDI-TOF MS with MS/MS.
|
Academic Article
|
Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer's Disease.
|
Academic Article
|
Phosphorylation of Tau protein correlates with changes in hippocampal theta oscillations and reduces hippocampal excitability in Alzheimer's model.
|
Academic Article
|
Mitofusin 2 Regulates Axonal Transport of Calpastatin to Prevent Neuromuscular Synaptic Elimination in Skeletal Muscles.
|
Academic Article
|
No Evidence of Increased Chronic Traumatic Encephalopathy Pathology or Neurodegenerative Proteinopathy in Former Military Service Members: A Preliminary Study.
|
Academic Article
|
Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.
|
Academic Article
|
Differences in structure and function between human and murine tau.
|
Academic Article
|
TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration.
|
Academic Article
|
TDP-43 inhibitory peptide alleviates neurodegeneration and memory loss in an APP transgenic mouse model for Alzheimer's disease.
|
Academic Article
|
Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances.
|
Academic Article
|
Decreased salivary lactoferrin levels are specific to Alzheimer's disease.
|
Academic Article
|
High molecular weight neurofilament proteins are physiological substrates of adduction by the lipid peroxidation product hydroxynonenal.
|
Academic Article
|
Amyloid-beta, tau alterations and mitochondrial dysfunction in Alzheimer disease: the chickens or the eggs?
|
Academic Article
|
Predicting the failure of amyloid-beta vaccine.
|
Academic Article
|
The neuroprotective activities of melatonin against the Alzheimer beta-protein are not mediated by melatonin membrane receptors.
|
Academic Article
|
Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins.
|
Academic Article
|
The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease.
|
Academic Article
|
Amyloid-beta: a (life) preserver for the brain.
|
Academic Article
|
Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice.
|
Academic Article
|
Role of high mobility group protein-1 (HMG1) in amyloid-beta homeostasis.
|
Academic Article
|
The role of mitogen-activated protein kinase pathways in Alzheimer's disease.
|
Academic Article
|
4-hydroxynonenal contributes to NGF withdrawal-induced neuronal apoptosis.
|
Academic Article
|
Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease.
|
Academic Article
|
Distribution, levels, and activation of MEK1 in Alzheimer's disease.
|
Academic Article
|
Cerebrovascular requirement for sealant, anti-coagulant and remodeling molecules that allow for the maintenance of vascular integrity and blood supply.
|
Academic Article
|
Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
|
Academic Article
|
Oxidative stress and neuronal adaptation in Alzheimer disease: the role of SAPK pathways.
|
Academic Article
|
Oxidative damage in cultured human olfactory neurons from Alzheimer's disease patients.
|
Academic Article
|
Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease.
|
Academic Article
|
Alzheimer's disease: the two-hit hypothesis.
|
Academic Article
|
Heme catabolism and heme oxygenase in neurodegenerative disease.
|
Academic Article
|
Microglial activation and amyloid-beta clearance induced by exogenous heat-shock proteins.
|
Academic Article
|
Oxidative stress increases expression and activity of BACE in NT2 neurons.
|
Academic Article
|
The p38 pathway is activated in Pick disease and progressive supranuclear palsy: a mechanistic link between mitogenic pathways, oxidative stress, and tau.
|
Academic Article
|
Amyloid-beta and tau serve antioxidant functions in the aging and Alzheimer brain.
|
Academic Article
|
Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells.
|
Academic Article
|
Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence.
|
Academic Article
|
JKK1, an upstream activator of JNK/SAPK, is activated in Alzheimer's disease.
|
Academic Article
|
Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation.
|
Academic Article
|
Functional implications of antiestrogen induction of quinone reductase: inhibition of estrogen-induced deoxyribonucleic acid damage.
|
Academic Article
|
Possible involvement of Wiskott-Aldrich syndrome protein family in aberrant neuronal sprouting in Alzheimer's disease.
|
Academic Article
|
Increased p27, an essential component of cell cycle control, in Alzheimer's disease.
|
Academic Article
|
Hydroxynonenal, toxic carbonyls, and Alzheimer disease.
|
Academic Article
|
Amyotrophic lateral sclerosis: a novel hypothesis involving a gained 'loss of function' in the JNK/SAPK pathway.
|
Academic Article
|
Oxidative damage in the olfactory system in Alzheimer's disease.
|
Academic Article
|
Will preventing protein aggregates live up to its promise as prophylaxis against neurodegenerative diseases?
|
Academic Article
|
Tipping the apoptotic balance in Alzheimer's disease: the abortosis concept.
|
Academic Article
|
Amyloid-beta-induced toxicity of primary neurons is dependent upon differentiation-associated increases in tau and cyclin-dependent kinase 5 expression.
|
Academic Article
|
Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition.
|
Academic Article
|
Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer's disease.
|
Academic Article
|
Prion protein is ubiquitinated after developing protease resistance in the brains of scrapie-infected mice.
|
Academic Article
|
Perspectives on the amyloid-beta cascade hypothesis.
|
Academic Article
|
Regulation of glycogen synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma cells.
|
Academic Article
|
Neuroprotective properties of Bcl-w in Alzheimer disease.
|
Academic Article
|
Tau phosphorylation and assembly.
|
Academic Article
|
Accelerated alpha-synuclein aggregation after differentiation of SH-SY5Y neuroblastoma cells.
|
Academic Article
|
Concealment of epitope by reduction and alkylation in prion protein.
|
Academic Article
|
Tau modifiers as therapeutic targets for Alzheimer's disease.
|
Academic Article
|
Mitogen- and stress-activated protein kinase 1: convergence of the ERK and p38 pathways in Alzheimer's disease.
|
Academic Article
|
Therapeutic potential of oxidant mechanisms in Alzheimer's disease.
|
Academic Article
|
MAPKs are differentially modulated in arctic ground squirrels during hibernation.
|
Academic Article
|
The cell cycle in Alzheimer disease: a unique target for neuropharmacology.
|
Academic Article
|
Neurotoxic dopamine quinone facilitates the assembly of tau into fibrillar polymers.
|
Academic Article
|
A second look into the oxidant mechanisms in Alzheimer's disease.
|
Academic Article
|
P38 activation mediates amyloid-beta cytotoxicity.
|
Academic Article
|
Neuropathology in Alzheimer's disease: awaking from a hundred-year-old dream.
|
Academic Article
|
Neuropathology of Alzheimer disease: pathognomonic but not pathogenic.
|
Academic Article
|
Ectopic expression of phospho-Smad2 in Alzheimer's disease: uncoupling of the transforming growth factor-beta pathway?
|
Academic Article
|
Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions.
|
Academic Article
|
Alzheimer disease, the two-hit hypothesis: an update.
|
Academic Article
|
c-Jun phosphorylation in Alzheimer disease.
|
Academic Article
|
Treating the lesions, not the disease.
|
Academic Article
|
Identification of the imprinted KLF14 transcription factor undergoing human-specific accelerated evolution.
|
Academic Article
|
Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations.
|
Academic Article
|
Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease.
|
Academic Article
|
Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron.
|
Academic Article
|
Tau phosphorylation in Alzheimer's disease: pathogen or protector?
|
Academic Article
|
Assembly in vitro of tau protein and its implications in Alzheimer's disease.
|
Academic Article
|
Alzheimer's disease: an intracellular movement disorder?
|
Academic Article
|
4-Oxo-2-nonenal is both more neurotoxic and more protein reactive than 4-hydroxy-2-nonenal.
|
Academic Article
|
Metal ions and oxidative protein modification in neurological disease.
|
Academic Article
|
Chitin-like polysaccharides in Alzheimer's disease brains.
|
Academic Article
|
Presenilin mutation: a deadly first hit in Alzheimer disease. A commentary on "aging sensitizes towards ROS formation and lipid peroxidation in PS1M146L transgenic mice".
|
Academic Article
|
Alpha-synuclein facilitates the toxicity of oxidized catechol metabolites: implications for selective neurodegeneration in Parkinson's disease.
|
Academic Article
|
Compensatory responses induced by oxidative stress in Alzheimer disease.
|
Academic Article
|
Antioxidant protection and neurodegenerative disease: the role of amyloid-beta and tau.
|
Academic Article
|
Therapeutic options in Alzheimer's disease.
|
Academic Article
|
Amyloid-beta, BACE, and oxidative stress in Alzheimer's disease, a commentary on "The different aggregation state of beta-amyloid 1-42 mediates different effects on oxidative stress, neurodegeneration and BACE-1 expression".
|
Academic Article
|
LRRK2 protein is a component of Lewy bodies.
|
Academic Article
|
Increased expression of p130 in Alzheimer disease.
|
Academic Article
|
Apoptosis in Alzheimer disease: a mathematical improbability.
|
Academic Article
|
Steroidogenic acute regulatory protein (StAR): evidence of gonadotropin-induced steroidogenesis in Alzheimer disease.
|
Academic Article
|
Neuropathology and treatment of Alzheimer disease: did we lose the forest for the trees?
|
Academic Article
|
Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein.
|
Academic Article
|
Physiological regulation of tau phosphorylation during hibernation.
|
Academic Article
|
Leucine-rich repeat kinase 2 colocalizes with alpha-synuclein in Parkinson's disease, but not tau-containing deposits in tauopathies.
|
Academic Article
|
Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer's disease.
|
Academic Article
|
Alzheimer disease pathology as a host response.
|
Academic Article
|
Phosphorylated tau: toxic, protective, or none of the above.
|
Academic Article
|
Retinoblastoma protein phosphorylation at multiple sites is associated with neurofibrillary pathology in Alzheimer disease.
|
Academic Article
|
Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease.
|
Academic Article
|
Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease.
|
Academic Article
|
The essential role of ERK in 4-oxo-2-nonenal-mediated cytotoxicity in SH-SY5Y human neuroblastoma cells.
|
Academic Article
|
The up-regulation of BACE1 mediated by hypoxia and ischemic injury: role of oxidative stress and HIF1alpha.
|
Academic Article
|
Molecular pathogenesis of Alzheimer's disease: reductionist versus expansionist approaches.
|
Academic Article
|
Tau--an inhibitor of deacetylase HDAC6 function.
|
Academic Article
|
Impaired balance of mitochondrial fission and fusion in Alzheimer's disease.
|
Academic Article
|
Ectopic localization of FOXO3a protein in Lewy bodies in Lewy body dementia and Parkinson's disease.
|
Academic Article
|
BRCA1 may modulate neuronal cell cycle re-entry in Alzheimer disease.
|
Academic Article
|
Oxidative stress is an early event in hydrostatic pressure induced retinal ganglion cell damage.
|
Academic Article
|
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes.
|
Academic Article
|
Stem cell niches as clinical targets: the future of anti-ischemic therapy?
|
Academic Article
|
The effect of mGluR2 activation on signal transduction pathways and neuronal cell survival.
|
Academic Article
|
Neuroprotective effect of cocoa flavonoids on in vitro oxidative stress.
|
Academic Article
|
Copper Induces Apoptosis of Neuroblastoma Cells Via Post-translational Regulation of the Expression of Bcl-2-family Proteins and the tx Mouse is a Better Model of Hepatic than Brain Cu Toxicity.
|
Academic Article
|
From aging to Alzheimer's disease: unveiling "the switch" with the senescence-accelerated mouse model (SAMP8).
|
Concept
|
Acute-Phase Proteins
|
Concept
|
Serum Amyloid A Protein
|
Concept
|
Anion Exchange Protein 1, Erythrocyte
|
Concept
|
Blood Proteins
|
Concept
|
Calcium-Binding Proteins
|
Concept
|
Calmodulin-Binding Proteins
|
Concept
|
Carrier Proteins
|
Concept
|
Complement System Proteins
|
Concept
|
Cytoskeletal Proteins
|
Concept
|
DNA-Binding Proteins
|
Concept
|
Glial Fibrillary Acidic Protein
|
Concept
|
Heat-Shock Proteins
|
Concept
|
Intermediate Filament Proteins
|
Concept
|
Iron-Sulfur Proteins
|
Concept
|
Luminescent Proteins
|
Concept
|
Membrane Proteins
|
Concept
|
Microfilament Proteins
|
Concept
|
Microtubule Proteins
|
Concept
|
Microtubule-Associated Proteins
|
Concept
|
Monosaccharide Transport Proteins
|
Concept
|
Muscle Proteins
|
Concept
|
S100 Proteins
|
Concept
|
Nerve Tissue Proteins
|
Concept
|
Nuclear Proteins
|
Concept
|
Protein Binding
|
Concept
|
Protein Conformation
|
Concept
|
Protein Denaturation
|
Concept
|
Protein Kinases
|
Concept
|
Protein Precursors
|
Concept
|
Protein Processing, Post-Translational
|
Concept
|
Protein-Tyrosine Kinases
|
Concept
|
Proteins
|
Concept
|
Proto-Oncogene Proteins
|
Concept
|
Recombinant Fusion Proteins
|
Concept
|
Recombinant Proteins
|
Concept
|
Repressor Proteins
|
Concept
|
Protein Biosynthesis
|
Concept
|
Protozoan Proteins
|
Concept
|
Tumor Suppressor Protein p53
|
Concept
|
Retinoblastoma Protein
|
Concept
|
Amyloid beta-Protein Precursor
|
Concept
|
RNA-Binding Proteins
|
Concept
|
Proto-Oncogene Proteins c-jun
|
Concept
|
tau Proteins
|
Concept
|
Neurofilament Proteins
|
Concept
|
Protein Structure, Secondary
|
Concept
|
Protein Structure, Tertiary
|
Concept
|
Protein Folding
|
Concept
|
MyoD Protein
|
Concept
|
Cyclic AMP-Dependent Protein Kinases
|
Concept
|
Calcium-Calmodulin-Dependent Protein Kinases
|
Concept
|
PrPSc Proteins
|
Concept
|
PrPC Proteins
|
Concept
|
Cell Cycle Proteins
|
Concept
|
HSP70 Heat-Shock Proteins
|
Concept
|
HSP90 Heat-Shock Proteins
|
Concept
|
Proto-Oncogene Proteins c-bcl-2
|
Concept
|
BRCA1 Protein
|
Concept
|
Protein Disulfide-Isomerases
|
Concept
|
Mitogen-Activated Protein Kinase 1
|
Concept
|
Protein Isoforms
|
Concept
|
I-kappa B Proteins
|
Concept
|
rab GTP-Binding Proteins
|
Concept
|
Mitogen-Activated Protein Kinases
|
Concept
|
Mitogen-Activated Protein Kinase Kinases
|
Concept
|
Protein Subunits
|
Concept
|
Protein Transport
|
Concept
|
Mitochondrial Proteins
|
Concept
|
HMGB1 Protein
|
Concept
|
BRCA2 Protein
|
Concept
|
Tumor Suppressor Proteins
|
Concept
|
Membrane Transport Proteins
|
Concept
|
Anion Transport Proteins
|
Concept
|
Cation Transport Proteins
|
Concept
|
Saccharomyces cerevisiae Proteins
|
Concept
|
Drosophila Proteins
|
Concept
|
Escherichia coli Proteins
|
Concept
|
Mitochondrial Membrane Transport Proteins
|
Concept
|
Iron-Regulatory Proteins
|
Concept
|
Iron Regulatory Protein 1
|
Concept
|
Iron Regulatory Protein 2
|
Concept
|
Ribosomal Protein S6
|
Concept
|
Ribosomal Protein S6 Kinases, 90-kDa
|
Concept
|
Receptors, G-Protein-Coupled
|
Concept
|
Ubiquitin-Protein Ligases
|
Concept
|
Electron Transport Chain Complex Proteins
|
Concept
|
Intracellular Signaling Peptides and Proteins
|
Concept
|
JNK Mitogen-Activated Protein Kinases
|
Concept
|
p38 Mitogen-Activated Protein Kinases
|
Concept
|
Mitogen-Activated Protein Kinase 3
|
Concept
|
Mitogen-Activated Protein Kinase 8
|
Concept
|
Mitogen-Activated Protein Kinase 9
|
Concept
|
Mitogen-Activated Protein Kinase 10
|
Concept
|
Adaptor Proteins, Signal Transducing
|
Concept
|
Green Fluorescent Proteins
|
Concept
|
Mutant Proteins
|
Concept
|
Retinoblastoma-Like Protein p130
|
Concept
|
CREB-Binding Protein
|
Concept
|
bcl-2 Homologous Antagonist-Killer Protein
|
Concept
|
Apoptosis Regulatory Proteins
|
Concept
|
bcl-X Protein
|
Concept
|
bcl-Associated Death Protein
|
Concept
|
bcl-2-Associated X Protein
|
Concept
|
Proto-Oncogene Proteins c-akt
|
Concept
|
Glucose Transport Proteins, Facilitative
|
Concept
|
Wiskott-Aldrich Syndrome Protein Family
|
Concept
|
Wiskott-Aldrich Syndrome Protein, Neuronal
|
Concept
|
Xeroderma Pigmentosum Group A Protein
|
Concept
|
Sterol Regulatory Element Binding Protein 2
|
Concept
|
Smad Proteins
|
Concept
|
Smad2 Protein
|
Concept
|
Amyloid Precursor Protein Secretases
|
Concept
|
Protein Phosphatase 2
|
Concept
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2
|
Concept
|
G-Protein-Coupled Receptor Kinase 2
|
Concept
|
Protein Multimerization
|
Academic Article
|
Mechanisms by which metals promote events connected to neurodegenerative diseases.
|
Academic Article
|
What is aging? What is its role in Alzheimer's disease? What can we do about it?
|
Academic Article
|
?-amyloid 1-42 induces physiological transcriptional regulation of BACE1.
|
Academic Article
|
Neurofilaments are the major neuronal target of hydroxynonenal-mediated protein cross-links.
|
Academic Article
|
PARK2 enhancement is able to compensate mitophagy alterations found in sporadic Alzheimer's disease.
|
Academic Article
|
Nucleic acid oxidative damage in Alzheimer's disease-explained by the hepcidin-ferroportin neuronal iron overload hypothesis?
|
Academic Article
|
Slower Dynamics and Aged Mitochondria in Sporadic Alzheimer's Disease.
|
Academic Article
|
An Inducible Alpha-Synuclein Expressing Neuronal Cell Line Model for Parkinson's Disease1.
|
Academic Article
|
Towards an Integrative Understanding of tRNA Aminoacylation-Diet-Host-Gut Microbiome Interactions in Neurodegeneration.
|
Academic Article
|
Analysis of the Relationship Between Metalloprotease-9 and Tau Protein in Alzheimer's Disease.
|
Academic Article
|
National Dementia BioBank: A Strategy for the Diagnosis and Study of Neurodegenerative Diseases in M?xico.
|
Academic Article
|
Neuroinflammation, hyperphosphorylated tau, diffuse amyloid plaques, and down-regulation of the cellular prion protein in air pollution exposed children and young adults.
|
Academic Article
|
Lester (Skip) Binder (1949-2013): in the beginning was tau.
|
Academic Article
|
Status and future directions of clinical trials in Alzheimer's disease.
|
Academic Article
|
Serial reconstruction of beta-protein amyloid plaques: relationship to microvessels and size distribution.
|
Academic Article
|
Senile plaques in cerebral amyloid angiopathy show accumulation of amyloid precursor protein without cytoskeletal abnormalities.
|
Academic Article
|
Filaments of Lewy bodies contain insoluble cytoskeletal elements.
|
Academic Article
|
Derivation and characterization of glycoinositol-phospholipid anchor-defective human K562 cell clones.
|
Academic Article
|
Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein.
|
Academic Article
|
Immunohistochemical recognition of ethylnitrosourea induced rat brain microtumors by anti-Leu 7 monoclonal antibody.
|
Academic Article
|
Age-dependent pattern of intermediate filament protein expression in the human pineal gland.
|
Academic Article
|
Ultrastructural localization of beta-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles.
|
Academic Article
|
Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease.
|
Academic Article
|
Coexistence of cytokeratin, vimentin and neurofilament protein in human choroid plexus. An immunohistochemical study of intermediate filaments in neuroepithelial tissues.
|
Academic Article
|
Lewy bodies contain epitopes both shared and distinct from Alzheimer neurofibrillary tangles.
|
Academic Article
|
Immunochemical properties of ubiquitin conjugates in the paired helical filaments of Alzheimer disease.
|
Academic Article
|
Immunoaffinity demonstration that paired helical filaments of Alzheimer disease share epitopes with neurofilaments, MAP2 and tau.
|
Academic Article
|
Tau-reactive neurofibrillary tangles in cerebellar cortex from patients with Alzheimer's disease.
|
Academic Article
|
Soluble derivatives of the beta amyloid protein precursor of Alzheimer's disease are labeled by antisera to the beta amyloid protein.
|
Academic Article
|
Immunolocalization of the amyloid precursor protein within the senile plaque.
|
Academic Article
|
Amyloid precursor protein in senile plaques of Alzheimer disease.
|
Academic Article
|
The amyloid percursor protein of Alzheimer disease is expressed as a 130 kDa polypeptide in various cultured cell types.
|
Academic Article
|
The glucose transporter of the human brain and blood-brain barrier.
|
Academic Article
|
Filaments of Pick's bodies contain altered cytoskeletal elements.
|
Academic Article
|
Paired helical filaments from Alzheimer disease patients contain cytoskeletal components.
|
Academic Article
|
Subcellular localization of amyloid precursor protein in senile plaques of Alzheimer's disease.
|
Academic Article
|
Cytokeratin expression in human spinal meninges and ependymal cells.
|
Academic Article
|
Beta protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease.
|
Academic Article
|
Dystrophic neurites infiltrate extracellular neurofibrillary tangles in Alzheimer disease.
|
Academic Article
|
Abnormal tau-reactive filaments in olfactory mucosa in biopsy specimens of patients with probable Alzheimer's disease.
|
Academic Article
|
Neuropil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton.
|
Academic Article
|
Glucose transporters are abundant in cells with "occluding" junctions at the blood-eye barriers.
|
Academic Article
|
The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease.
|
Academic Article
|
Immunocytochemical localization of the erythroid glucose transporter: abundance in tissues with barrier functions.
|
Academic Article
|
The presence of tau distinguishes Lewy bodies of diffuse Lewy body disease from those of idiopathic Parkinson disease.
|
Academic Article
|
The widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid deposition.
|
Academic Article
|
Amyloid precursor protein in cell cultures: a 130 kDa polypeptide.
|
Academic Article
|
Ultrastructural localization of erythrocyte cytoskeletal and integral membrane proteins in Plasmodium falciparum-infected erythrocytes.
|
Academic Article
|
Hirano body filaments contain actin and actin-associated proteins.
|
Academic Article
|
Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy.
|
Academic Article
|
Hirano bodies contain tau protein.
|
Academic Article
|
Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide.
|
Academic Article
|
Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease.
|
Academic Article
|
Immunochemical identification of ubiquitin and heat-shock proteins in corpora amylacea from normal aged and Alzheimer's disease brains.
|
Academic Article
|
Early AGEing and Alzheimer's.
|
Academic Article
|
Barrier properties of testis microvessels.
|
Academic Article
|
Alzheimer's disease and prion proteins: a meeting made in muscle.
|
Academic Article
|
Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease.
|
Academic Article
|
The amyloid precursor protein in ischemic brain injury and chronic hypoperfusion.
|
Academic Article
|
beta PP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's disease.
|
Academic Article
|
Alterations of low molecular weight acid phosphatase protein level in Alzheimer's disease.
|
Academic Article
|
APP transgenesis: approaches toward the development of animal models for Alzheimer disease neuropathology.
|
Academic Article
|
Artifactual strain-specific signs of incipient brain amyloidosis in APP transgenic mice.
|
Academic Article
|
alpha-calcium-calmodulin-dependent kinase II is associated with paired helical filaments of Alzheimer's disease.
|
Academic Article
|
Filament heterogeneity within the dystrophic neurites of senile plaques suggests blockage of fast axonal transport in Alzheimer's disease.
|
Academic Article
|
Trypsin interaction with the senile plaques of Alzheimer disease is mediated by beta-protein precursor.
|
Academic Article
|
Antibodies to neurofibrillary tangles of Alzheimer's disease raised from human and animal neurofilament fractions.
|
Academic Article
|
Production of monoclonal antibodies against calmodulin by in vitro immunization of spleen cells.
|
Academic Article
|
Association of apolipoprotein E with murine amyloid A protein amyloid.
|
Academic Article
|
Immunocytochemical evidence that the beta-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease.
|
Academic Article
|
T-cell reconstitution by molecular, phenotypic, and functional analysis in the thymus, bone marrow, spleen, and blood following split-dose polychemotherapy and therapeutic activity for metastatic breast cancer in mice.
|
Academic Article
|
Amyloid P component and other acute-phase proteins associated with cerebellar A beta-deposits in Alzheimer's disease.
|
Academic Article
|
Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease.
|
Academic Article
|
Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease.
|
Academic Article
|
Apolipoprotein E interaction with the neurofibrillary tangles and senile plaques in Alzheimer disease: implications for disease pathogenesis.
|
Academic Article
|
Characterization of the association of phospholipase C-delta with Alzheimer neurofibrillary tangles.
|
Academic Article
|
Alteration of phospholipase C-delta protein level and specific activity in Alzheimer's disease.
|
Academic Article
|
Radical AGEing in Alzheimer's disease.
|
Academic Article
|
Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease.
|
Academic Article
|
beta-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal outgrowth.
|
Academic Article
|
Identification and transport of full-length amyloid precursor proteins in rat peripheral nervous system.
|
Academic Article
|
Accumulation of the beta amyloid precursor protein at sites of ischemic injury in rat brain.
|
Academic Article
|
Ontogeny of the erythroid/HepG2-type glucose transporter (GLUT-1) in the rat nervous system.
|
Academic Article
|
Rimmed vacuoles of inclusion body myositis and oculopharyngeal muscular dystrophy contain amyloid precursor protein and lysosomal markers.
|
Academic Article
|
Quantitative solubilization and analysis of insoluble paired helical filaments from Alzheimer disease.
|
Academic Article
|
Oxidative posttranslational modifications in Alzheimer disease. A possible pathogenic role in the formation of senile plaques and neurofibrillary tangles.
|
Academic Article
|
Is amyloid beta-protein glycated in Alzheimer's disease?
|
Academic Article
|
Levuglandin E2-protein adducts in human plasma and vasculature.
|
Academic Article
|
Alzheimer disease: protein-protein interaction and oxidative stress.
|
Academic Article
|
Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo.
|
Academic Article
|
Abnormal localization of iron regulatory protein in Alzheimer's disease.
|
Academic Article
|
Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress.
|
Academic Article
|
Altered glycosylation pattern of proteins in Alzheimer disease.
|
Academic Article
|
Dimethylargininase, a nitric oxide regulatory protein, in Alzheimer disease.
|
Academic Article
|
The mosaic of brain glial hyperactivity during normal ageing and its attenuation by food restriction.
|
Academic Article
|
CI-ATPase and Na+/K(+)-ATPase activities in Alzheimer's disease brains.
|
Academic Article
|
In situ methods for detection and localization of markers of oxidative stress: application in neurodegenerative disorders.
|
Academic Article
|
Prion protein glycosylation is sensitive to redox change.
|
Academic Article
|
How important is oxidative damage? Lessons from Alzheimer's disease.
|
Academic Article
|
In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification.
|
Academic Article
|
Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease.
|
Academic Article
|
Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein.
|
Academic Article
|
Protein disulfide isomerase in Alzheimer disease.
|
Academic Article
|
Biochemistry of neurodegeneration.
|
Academic Article
|
Evidence for a novel heme-binding protein, HasAh, in Alzheimer disease.
|
Academic Article
|
Induction of NADPH cytochrome P450 reductase by the Alzheimer beta-protein. Amyloid as a "foreign body".
|
Academic Article
|
Early glycoxidation damage in brains from Down's syndrome.
|
Academic Article
|
Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease.
|
Academic Article
|
Is oxidative damage central to the pathogenesis of Alzheimer disease?
|
Academic Article
|
A suicide note from Alzheimer disease neurons?
|
Academic Article
|
Universal isolation of cross-linked peptides: application to neurofibrillary tangles.
|
Academic Article
|
Is increased redox-active iron in Alzheimer disease a failure of the copper-binding protein ceruloplasmin?
|
Academic Article
|
Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation.
|
Academic Article
|
In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals.
|
Academic Article
|
Overexpression of heme oxygenase in neuronal cells, the possible interaction with Tau.
|
Academic Article
|
Prospects for noninvasive imaging of brain amyloid beta in Alzheimer's disease.
|
Academic Article
|
Lipoperoxidation is selectively involved in progressive supranuclear palsy.
|
Academic Article
|
Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation.
|
Academic Article
|
Activation of p38 kinase links tau phosphorylation, oxidative stress, and cell cycle-related events in Alzheimer disease.
|
Academic Article
|
Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4-hydroxy-2-nonenal.
|
Academic Article
|
Induction of HO-1 and NOS in doppel-expressing mice devoid of PrP: implications for doppel function.
|
Academic Article
|
Melatonin acts as antioxidant and pro-oxidant in an organotypic slice culture model of Alzheimer's disease.
|
Academic Article
|
Abortive apoptosis in Alzheimer's disease.
|
Academic Article
|
Chemistry and biochemistry of oxidative stress in neurodegenerative disease.
|
Academic Article
|
Differential activation of neuronal ERK, JNK/SAPK and p38 in Alzheimer disease: the 'two hit' hypothesis.
|
Academic Article
|
Activation of MKK6, an upstream activator of p38, in Alzheimer's disease.
|
Academic Article
|
Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB.
|
Academic Article
|
Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy.
|
Academic Article
|
Possible involvement of ER chaperone Grp78 on reduced formation of amyloid-beta deposits.
|
Academic Article
|
Possible protective mechanisms of heme oxygenase-1 in the brain.
|
Academic Article
|
Neurofilament proteins in neurodegenerative diseases.
|
Academic Article
|
Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways.
|
Academic Article
|
Retinoic acid isomers protect hippocampal neurons from amyloid-beta induced neurodegeneration.
|
Academic Article
|
Synaptic dysfunction and oxidative stress in Alzheimer's disease: emerging mechanisms.
|
Academic Article
|
Brain and brawn: parallels in oxidative strength.
|
Academic Article
|
Conformational changes and cleavage of tau in Pick bodies parallel the early processing of tau found in Alzheimer pathology.
|
Academic Article
|
Abnormal mitochondrial dynamics--a novel therapeutic target for Alzheimer's disease?
|
Academic Article
|
Prospects on the origin of Alzheimer's disease.
|
Academic Article
|
A novel perspective on tau in Alzheimer's disease.
|
Academic Article
|
Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome.
|
Academic Article
|
Dysfunctional tubular endoplasmic reticulum constitutes a pathological feature of Alzheimer's disease.
|
Academic Article
|
Inhibition of Calpain Protects Against Tauopathy in Transgenic P301S Tau Mice.
|
Academic Article
|
Genomic Evidence for Local Adaptation of Hunter-Gatherers to the African Rainforest.
|
Academic Article
|
Phospho-Tau Protein Expression in the Cell Cycle of SH-SY5Y Neuroblastoma Cells: A Morphological Study.
|
Academic Article
|
Polygenic adaptation and convergent evolution on growth and cardiac genetic pathways in African and Asian rainforest hunter-gatherers.
|
Grant
|
RCMI Center for Interdiscplinary Health Research CIHR
|
Grant
|
RCMI Center for Interdiscplinary Health Research CIHR
|
Grant
|
AMYLOID PRECURSOR IN ALZHEIMER DISEASE
|
Grant
|
NEUROFIBRILLARY PATHOLOGY IN ALZHEIMER DISEASE
|
Academic Article
|
Ethanol-Fixed, Paraffin-Embedded Tissue Imaging: Implications for Alzheimer's Disease Research.
|
Academic Article
|
Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration.
|
Academic Article
|
A Multilevel View of the Development of Alzheimer's Disease.
|
Academic Article
|
Immune modulations and immunotherapies for Alzheimer's disease: a comprehensive review.
|
Academic Article
|
Hyperphosphorylated Tau Relates to Improved Cognitive Performance and Reduced Hippocampal Excitability in the Young rTg4510 Mouse Model of Tauopathy.
|
Academic Article
|
Hypoxic Preconditioning Averts Sporadic Alzheimer's Disease-Like Phenotype in Rats: A Focus on Mitochondria.
|
Academic Article
|
The Amyloid-? Pathway in Alzheimer's Disease.
|
Academic Article
|
The Anti-Amyloid Monoclonal Antibody Lecanemab: 16 Cautionary Notes.
|
Academic Article
|
Memory, Sleep, and Tau Function.
|
Academic Article
|
MicroRNA networks linked with BRCA1/2, PTEN, and common genes for Alzheimer's disease and breast cancer share highly enriched pathways that may unravel targets for the AD/BC comorbidity treatment.
|
Academic Article
|
Passive Alzheimer's immunotherapy: A promising or uncertain option?
|
Academic Article
|
Revision of Alzheimer's diagnostic criteria or relocation of the Potemkin village.
|
Academic Article
|
Evaluation of N- and O-Linked Indole Triazines for a Dual Effect on a-Synuclein and Tau Aggregation.
|
Academic Article
|
Sex-Specific Early Retinal Dysfunction in Mutant TDP-43 Transgenic Mice.
|